You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -152.1% | -10.8% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 27.4 | 3.9 |
| Price / Book value | 31.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 11.47 | -0.33 | €0.00 | 729.7 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 17.91 | -0.91 | €-0.01 | -21.2 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 17.41 | -1.80 | €-0.03 | -4.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -1.66 | €-7.85 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 3.84 | -6.62 | €-0.04 | -1.4 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 22.87 | -2.48 | -0.77p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 31.57 | 3.90 | -0.09p | 14.9 | n/a | 0% | 0.00p | 0.0% |
| Open Orphan secures study trial contract with mystery pharmaceutical company Sharecast News | 10 Aug |
|---|---|
| Open Orphan signs new pharma trial contract with Carna Sharecast News | 04 Aug |
| Open Orphan to conduct in-human trials on Covid-19 intranasal vaccine candidate Sharecast News | 28 Jul |
| Major New Contract Win with Top 3 Pharma Company | 10-Aug-20 07:07 |
|---|---|
| New Contract Win with Carna Bioscience ("Carna") | 04-Aug-20 07:04 |
| Contract for COVID-19 Vaccine Trial | 28-Jul-20 07:05 |
| Result of AGM | 22-Jul-20 12:44 |
| Euronext Growth Dublin Notice | 10-Jul-20 08:01 |